Table 1.
Characteristics of the 42 patients sampled for C. albicans
| Patient* | Residence† | Age | Gender | CD4‡ | Hospitalization | Drug§ | Date,¶ day/month | Genotype (no., serotype)‖ |
|---|---|---|---|---|---|---|---|---|
| 1 | Abidjan | 32 | M | 27 | No | NYS | 07/05 | G1 (5, A) |
| 2 | Abidjan | 28 | M | 102 | No | AMB | 12/05 | G2 (5, A) |
| 3 | Abidjan | 51 | M | 87 | No | AMB | 26/05 | G3 (4, A), G4 (1, A) |
| 09/06 | G3 (3, A), G4 (2, A) | |||||||
| 4 | Abidjan | 33 | F | 8 | Yes | NYS | 27/05 | G5 (5, A) |
| 10/06 | G5 (5, A) | |||||||
| 5 | Abidjan | 18 | M | 15 | No | KTZ | 03/06 | G3 (5, A) |
| 17/06 | G3 (5, A) | |||||||
| 6 | Suburb | 21 | M | 11 | Yes | AMB | 03/06 | G3 (5, A) |
| 17/06 | G3 (5, A) | |||||||
| 7 | Abidjan | 30 | F | 38 | Yes | AMB | 08/06 | G6 (4, A), G7 (1, B) |
| 8 | Abidjan | 20 | M | 22 | Yes | AMB | 21/06 | G3 (5, A) |
| 9 | Abidjan | 35 | M | 32 | Yes | KTZ | 29/06 | G8 (5, A) |
| 10 | Abidjan | 42 | F | 44 | No | KTZ | 29/06 | G9 (1, A), G10 (1, A),G11 (2, B), G12 (1, A) |
| 11 | Suburb | 19 | M | 221 | No | KTZ | 05/07 | G13 (5, A) |
| 19/07 | G14 (5, A) | |||||||
| 12 | Abidjan | 19 | M | 25 | Yes | NYS | 08/07 | G15 (5, B) |
| 13 | Abidjan | 27 | M | 101 | Yes | KTZ | 13/07 | G16 (5, A) |
| 27/07 | G16 (5, A) | |||||||
| 14 | Abidjan | 34 | M | 22 | No | NYS | 14/07 | G3 (5, A) |
| 28/07 | G17 (5, A) | |||||||
| 15 | Abidjan | 31 | F | 16 | Yes | AMB | 16/07 | G7 (5, B) |
| 16 | Suburb | 39 | M | 27 | No | KTZ | 16/07 | G8 (5, A) |
| 17 | Abidjan | 25 | F | 47 | No | NYS | 16/07 | G18 (5, A) |
| 18 | Abidjan | 26 | F | 17 | No | AMB | 19/07 | G19 (5, A) |
| 19 | Abidjan | 30 | M | 8 | Yes | AMB | 22/07 | G7 (5, B) |
| 05/08 | G7 (5, B) | |||||||
| 20 | Suburb | 27 | M | 8 | Yes | AMB | 24/07 | G20 (5, A) |
| 21 | Abidjan | 37 | F | 31 | No | KTZ | 26/07 | G21 (5, A) |
| 22 | Suburb | 41 | F | 71 | No | KTZ | 30/07 | G22 (5, A) |
| 23 | Suburb | 52 | M | 44 | Yes | AMB | 31/07 | G23 (5, A) |
| 14/08 | G23 (5, A) | |||||||
| 24 | Abidjan | 26 | M | 22 | Yes | AMB | 04/08 | G23 (5, A) |
| 18/08 | G24 (5, A) | |||||||
| 25 | Abidjan | 33 | M | 9 | No | NYS | 10/08 | G25 (5, A) |
| 26 | Abidjan | 25 | F | 12 | No | KTZ | 12/08 | G15 (5, B) |
| 27 | Abidjan | 19 | F | 44 | No | NYS | 17/08 | G26 (5, A) |
| 31/08 | G18 (2, B), G19 (3, B) | |||||||
| 28 | Abidjan | 21 | F | 11 | Yes | NYS | 20/08 | G15 (5, A) |
| 03/09 | G15 (5, A) | |||||||
| 29 | Abidjan | 21 | M | 18 | Yes | KTZ | 22/08 | G15 (5, A) |
| 30 | Suburb | 37 | M | 44 | Yes | KTZ | 08/06 | G27 (5, A) |
| 31 | Abidjan | 40 | M | 27 | No | KTZ | 10/06 | G28 (5, A) |
| 32 | Abidjan | 25 | F | 38 | Yes | KTZ | 19/06 | G29 (5, B) |
| 03/07 | G29 (5, B) | |||||||
| 33 | Abidjan | 28 | F | 51 | No | KTZ | 03/07 | G15 (4, B), G27 (1, B) |
| 34 | Abidjan | 31 | F | 33 | No | KTZ | 11/07 | G30 (5, B) |
| 35 | Abidjan | 18 | M | 22 | No | KTZ | 11/07 | G31 (5, A) |
| 36 | Suburb | 16 | F | 22 | Yes | KTZ | 14/07 | G32 (3, A), G33 (2, A) |
| 37 | Abidjan | 21 | F | 11 | Yes | KTZ | 06/08 | G34 (5, A) |
| 38 | Abidjan | 33 | M | 9 | Yes | KTZ | 12/08 | G34 (1, B), G35 (3, B), G36 (1, B) |
| 39 | Abidjan | 19 | M | 44 | No | KTZ | 20/08 | G34 (5, A) |
| 40 | Suburb | 22 | F | 285 | No | KTZ | 20/08 | G34 (5, A) |
| 41 | Abidjan | 32 | F | 46 | Yes | KTZ | 24/08 | G30 (5, A) |
| 42 | Abidjan | 43 | F | 8 | No | KTZ | 27/08 | G37 (5, B) |
*Relapsing patients are in boldface type.
†Residence: City (Abidjan) or periphery (Suburb).
‡CD4 is T cell count per mm3 of blood.
§AMB, amphotericin B; NYS, nystatin; KTZ, ketoconazole.
¶Date: 1997 for patients 1–29; 1998 for patients 30–42.
‖The 37 multilocus genotypes are given in Table 2; data in parentheses indicate the number of samples with a given genotype and serotype A or B. Multilocus genotypes in italics were found in only one patient.